Clinical updates, including trial initiations, enrollment status and data readouts and publications: Assembly, Braintree, Eledon, Eli Lilly, OS, Palisade, Sellas, Spinogenix.
Minghui Pharmaceutical Ltd. announced it is raising $131 million in a pre-IPO financing round Aug. 7. The funds will be used to advance its cancer and inflammatory disease pipeline, which include a PD-1/VEGF bispecific antibody, antibody-drug conjugates (ADCs) and a topical Janus kinase inhibitor.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bionano, Bridge to Life, Caredx, Implantica, Paragonix.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aicuris, Crystal, HMNC, Sana, Urogen, Vertex, Windtree.
RSS
